FDA Inspection 1198206 — Aizant Drug Research Solutions Private Ltd.

Aizant Drug Research Solutions Private Ltd. — FEI 3008243902

The FDA completed an inspection of Aizant Drug Research Solutions Private Ltd. on January 25, 2023 in Hyderabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 25, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Hyderabad (India)

Additional Details

Clinical BA/BE